Reviews/Iron Status/Iron aids endurance in athletes
Func · IRON-FUNC-02 · v2
The studies here suggest that giving iron to athletes who are low in iron but not anaemic can help their bodies use energy more efficiently and hold a steady breathing threshold during exercise [2], [3], and one study found it reduced how tired athletes felt [1]. But the only trial that measured a genuine endurance test — how long runners could keep going before exhaustion, and their peak oxygen use — found no benefit from iron [5]. So the wins are on indirect efficiency measures, not on actual endurance performance. Almost all of the positive evidence comes from athletes who were already iron-deficient, not from athletes with normal iron who happen not to be anaemic. Because the claim promises improved endurance across non-anaemic athletes broadly, and the corpus only supports efficiency gains in the iron-deficient subgroup with a null result on the one hard test, the panel treated it as unsettled.
Three randomised trials in iron-deficient non-anemic athletes show iron improves efficiency-related surrogates: [2] prevented the decline in ventilatory threshold (P=0.01) and increased gross energetic efficiency (P=0.04) in 20 trained men and women, and [3] improved energetic efficiency (P=0.03 for group-by-time) and slowed lactate response in female rowers. In a general non-anemic athlete sample, [1] reported a significant reduction in tired feeling and exhaustion after exercise (P=0.05) and lower total mood disturbance in female athletes (P=0.016). Against these, [5] found no difference between iron and placebo in VO2max, running economy, or time to exhaustion (P>0.05) in iron-deficient nonanemic elite runners given IV iron. The demonstrated effects are on efficiency and subjective endpoints, not on measured endurance performance. The contested point: The evidence divides on whether iron improves endurance itself or only efficiency surrogates: the positive results in [2] and [3] are ventilatory threshold and energetic efficiency, while the single trial testing a hard endurance endpoint [5] was null on VO2max and time to exhaustion. It also divides on population — the positive signal sits within the iron-deficient subgroup, whereas the claim asserts non-anaemic athletes broadly.
All 10 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.
We’ll also send you other claims from Iron Status, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.
One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.
Surrogate/indirect outcomes: positive results are ventilatory threshold and energetic efficiency [2], [3], not endurance performance. The only trial measuring a hard endurance endpoint — time to exhaustion and VO2max [5] — was null.
Population overreach: nearly all positive evidence is in iron-DEFICIENT non-anemic (IDNA) subjects, whereas the claim asserts 'non-anaemic athletes' broadly. Iron-replete non-anemic athletes are essentially untested; the one general non-anemic athlete sample [1] measured subjective fatigue, not endurance.
Where it remains uncertain. The only trial measuring a hard endurance outcome found no benefit to VO2max or time to exhaustion [5], and nearly all positive evidence is confined to iron-deficient rather than all non-anemic athletes.
Aleatory
Hard-outcome trials had 15–40 completers ([5] N=15; [3] 31 completed), too few to reliably detect modest performance effects, so random variation can mask a true effect either way.
Epistemic
Positive evidence sits within iron-deficient non-anemic subjects; iron-replete non-anemic athletes are essentially unstudied in this corpus, so the broad claim rests on absent data.
The load-bearing papers from a corpus of 10, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.
Supporting but indirect: reduced subjective post-exercise exhaustion in general non-anemic athletes; not an objective endurance-performance measure.
“Also, a significant reduction in tired feeling/exhaustion after the exercise (P = 0.05; F = 4.07) between the placebo and iron intake groups was noticed.”
Panel auditInternal validity: medium · scope of inference: Non-anemic male and female athletes with sweating exercise habits, for mood/fatigue/sweating outcomes over four weeks.Key limitations: no endurance outcome · very low iron dose · subjective self-report measures
Positive: iron preserves ventilatory threshold and improves energetic efficiency in iron-deficient non-anemic trained subjects — a direct endurance-capacity surrogate.
“Iron supplementation prevented the decline in ventilatory threshold (VT) observed in the placebo group from pre- to post-supplementation (P=0.01); this effect was greater in individuals with lower sFer before intervention (P<0.05).”
Panel auditInternal validity: medium · scope of inference: Iron-deficient (low ferritin) but nonanemic trained men and women, aged 18-41, for ventilatory threshold and energetic efficiency.Key limitations: small sample · population is iron-deficient nonanemic, not all non-anemic athletes · surrogate endurance markers not a race outcome
Positive: improved energetic efficiency and lactate response in non-anemic iron-depleted female rowers during endurance exercise.
“Rowers in the Fe group had slower lactate response during the first half of the time trial and after 5 min of recovery (P = 0.05) and showed greater improvements in energy expenditure (P = 0.01 for group-by time) and energetic EF compared with placebo (P = 0.03 for group-by time).”
Panel auditInternal validity: medium · scope of inference: Iron-depleted nonanemic female rowers during a training season, for energetic efficiency and lactate response.Key limitations: dropout · female rowers only · efficiency surrogate rather than time-trial result
3 of 10 papers shown. The full review lists all of them, with the panel’s arbitration →
Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.
Genuine but surrogate-limited RCT support in iron-deficient non-anemic athletes is offset by a null hard-outcome trial and overreach on both the outcome ('endurance') and the population ('non-anaemic athletes' generally).
Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.
Assumptions that carry weight but are not themselves established.
The panel records the gap that would most move the claim, and the study that would close it.
Hard endurance endpoint in non-anemic athletes. The positive evidence is confined to efficiency surrogates [2], [3] while the sole hard-outcome trial [5] was null, so improved endurance performance itself is unestablished. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: Adequately powered RCT of iron supplementation in non-anemic athletes with a pre-registered hard endurance primary endpoint such as time trial or time to exhaustion.
Open question: Does iron supplementation improve a hard endurance performance outcome in non-anemic athletes, not just efficiency surrogates? Why it is still open: The efficiency gains in [2] and [3] are surrogates, and the one trial measuring VO2max and time to exhaustion [5] found no benefit.
Priors is a sceptical first reader, not peer review, and not medical advice.
Release 2026-q4 · graded 18 Sep 2026 · protocol v0.19